Paysign (NASDAQ:PAYS) EVP Joan Herman Sells 38,900 Shares

Paysign, Inc. (NASDAQ:PAYS) EVP Joan Herman sold 38,900 shares of the business’s stock in a transaction that occurred on Wednesday, September 16th. The shares were sold at an average price of $11.74, for a total transaction of $456,686.00. Following the sale, the executive vice president owned 609,421 shares of the company’s stock, valued at $7,154,602.54. This trade represents a 6.00% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Paysign Price Performance

Shares of PAYS stock opened at $12.42 on Friday. The company has a market cap of $701.23 million, a price-to-earnings ratio of 47.77 and a beta of 0.80. Paysign, Inc. has a 1 year low of $3.08 and a 1 year high of $14.43. The firm has a fifty day moving average price of $11.46 and a 200-day moving average price of $8.01.

Paysign (NASDAQ:PAYS) last released its earnings results on Wednesday, August 5th. The company reported $0.11 earnings per share for the quarter, beating the consensus estimate of $0.06 by $0.05. Paysign had a return on equity of 30.13% and a net margin of 15.67%.The company had revenue of $28.25 million for the quarter, compared to the consensus estimate of $26.36 million. Paysign has set its FY 2026 guidance at 0.350-0.370 EPS and its Q3 2026 guidance at 0.090-0.100 EPS. Equities research analysts expect that Paysign, Inc. will post 0.58 EPS for the current year.

Wall Street Analyst Weigh In

Several research firms recently issued reports on PAYS. DA Davidson increased their target price on shares of Paysign from $9.00 to $12.00 and gave the stock a “buy” rating in a report on Thursday, August 6th. Wall Street Zen lowered shares of Paysign from a “strong-buy” rating to a “buy” rating in a research report on Sunday, August 16th. Weiss Ratings raised shares of Paysign from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Wednesday, July 29th. Barrington Research set a $15.00 price objective on shares of Paysign in a research report on Tuesday, August 11th. Finally, Lake Street Capital lifted their target price on shares of Paysign from $13.00 to $15.00 and gave the company a “buy” rating in a research note on Tuesday. Three investment analysts have rated the stock with a Buy rating, According to MarketBeat, the stock has a consensus rating of “Buy” and an average price target of $14.00.

Hedge Funds Weigh In On Paysign

Hedge funds and other institutional investors have recently modified their holdings of the stock. Tidal Investments LLC purchased a new position in Paysign during the second quarter valued at $121,000. Connective Capital Management LLC bought a new position in shares of Paysign during the 2nd quarter valued at about $327,000. Corient Private Wealth LP grew its position in shares of Paysign by 69.8% during the second quarter. Corient Private Wealth LP now owns 30,159 shares of the company’s stock valued at $247,000 after purchasing an additional 12,396 shares in the last quarter. Punch & Associates Investment Management Inc. bought a new position in Paysign during the second quarter valued at $16,983,000. Finally, Bank of America Corp DE purchased a new position in shares of Paysign during the second quarter valued at approximately $335,000. Institutional investors own 25.89% of the company’s stock.

Paysign Company Profile

Paysign, Inc is a financial technology company that provides payment and financial services primarily to the healthcare and pharmaceutical industries. Its platform supports prepaid card programs, digital payments and other disbursement solutions designed to help organizations distribute funds to individuals efficiently and securely.

The company’s services include patient assistance programs that help eligible patients receive financial support for prescription medications and other healthcare costs.